The latest news in rare cancer tumour types including sarcomas
Cancer of unknown primary (CUP), a set of histologically confirmed metastases that cannot be identified…
On March 26, 2025, the Food and Drug Administration approved cabozantinib (Cabometyx, Exelixis, Inc.) for…
Glioma, the most common primary malignant tumour of the central nervous system, presents significant clinical…
Thymic epithelial tumours are a rare group of malignancies originating in the thymus gland, that…
In a new review published in Oncotarget, authors Elodie Verdier, Nathalie Gaspar, Maria Eugenia Marques…
Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common…
A new study examining the real-world implications of interrupting endocrine therapy (ET) for pregnancy in…
A new drug delivery system shows promise for treating a rare, aggressive form of cancer…
Omico, the not-for-profit genomics pioneer, has formally proposed a ‘first of its kind,’ transformative model…
Which medicine is best when you are affected by cancer? This can vary from person to…